From Twitter today.
"Our improved #Propofol #TPM® formulation has now successfully passed critical safety studies, supporting its use for continuous 24 hour infusion. This is big win, allowing us to recommence commercial discussions"
I wonder who the discussions are being recommenced with?
Ann: Improved Propofol TPM Formulation Passes Toxicology Study, page-18
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.604K | 534.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 41272233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 39672334 | 32 |
View Market Depth
| Last trade - 15.59pm 18/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |